Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[ 18f]fluoro-2-deoxy-d-glucose

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 5, 2004, Pages 1295-1300

  Allal, Abdelkarim S ^a,b   Slosman, Daniel O ^a   Kebdani, Tayeb ^a   Allaoua, Mohamed ^a   Lehmann, Willy ^a   Dulguerov, Pavel ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

FDG PET; Head and neck cancer; Predictive factor

Indexed keywords

CANCER PATIENTS; LOCAL CONTROL (LC);

CHEMOTHERAPY; GLUCOSE; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; SURGERY; TUMORS;

PATIENT MONITORING;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 3242716152     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.12.039     Document Type: Article

References (24)

1. Ang K.K., Trotti A., Brown B.W., et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 51:2001;571-578
2. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared with conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head and neck cancers Results of the EORTC 22851 randomized trial. Radiother Oncol. 44:1997;111-121
3. Allal A.S., Bieri S., Miralbell R., et al. Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas A comparison of toxicity and treatment results with those observed after radiotherapy alone. Ann Oncol. 8:1997;681-684
4. Chiesa F., Mauri S., Tradati N., et al. Surfing prognostic factors in head and neck cancer at the millennium. Oral Oncol. 35:1999;590-596
5. Wong R.J., Lin D.T., Schoder H., et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol. 20:2002;4199-4208
6. Tucker R., Coel M., Ko J., et al. Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on patient management First year's experience in a clinical center. J Clin Oncol. 19:2001;2504-2508
7. Vansteenkiste J.F., Stroobants S.G., Dupont P.J., et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose- positron emission tomography scan in non-small-cell lung cancer An analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol. 17:1999;3201-3206
8. Halfpenny W., Hain S.F., Biassoni L., et al. FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer. 86:2002;512-516
9. Oshida M., Uno K., Suzuki M., et al. Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro [18F]-D-glucose. Cancer. 82:1998;2227-2234
10. 18F]fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol. 20:2002;1398-1404
11. Haenggeli C.A., Dulguerov P., Slosman D., et al. Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma. Schweiz Med Wochenschr. 116:(Suppl. 1):2000;8-11
12. Sobin L.H., Wittekind C.h. UICC TNM classification of malignant tumors. 5th ed:1997;Springler-Verlag, Berlin
13. Allal A.S., de Pree C., Dulguerov P., et al. Avoidance of treatment interruption An unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas? Int J Radiat Oncol Biol Phys. 45:1999;41-45
14. van Tinteren H., Hoekstra O.S., Smit E.F., et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer The PLUS multicentre randomised trial. Lancet. 359:2002;1388-1393
15. Brun E., Ohlsson T., Erlandsson K., et al. Early prediction of treatment outcome in head and neck cancer with 2-18FDG PET. Acta Oncol. 36:1997;741-747
16. Kitagawa Y., Sadato N., Azuma H., et al. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms. J Nucl Med. 40:1999;1132-1137
17. Minn H., Lapela M., Klemi P.J., et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med. 38:1997;1907-1911
18. Minn H., Clavo A.C., Grenman R., et al. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med. 36:1995;252-258
19. Haberkorn U., Strauss L.G., Reisser C., et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors Relation of positron emission tomography to flow cytometry. J Nucl Med. 32:1991;1548-1555
20. Clavo A.C., Brown R.S., Wahl R.L. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med. 36:1995;1625-1632
21. Furuta M., Hasegawa M., Hayakawa K., et al. Rapid rise in FDG uptake in an irradiated human tumour xenograft. Eur J Nucl Med. 24:1997;435-438
22. Crippa F., Seregni E., Agresti R., et al. Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer A preliminary observation. Eur J Nucl Med. 25:1998;1429-1434
23. Hoekstra C.J., Paglianiti I., Hoekstra O.S., et al. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography An overview of different analytical methods. Eur J Nucl Med. 27:2000;731-743
24. Brun E., Kjellen E., Tennvall J., et al. FDG PET studies during treatment Prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck. 24:2002;127-135